From Big Data to Smart Data for Pharmacovigilance: The Role of Healthcare Databases and Other Emerging Sources
Author
Abstract
Suggested Citation
DOI: 10.1007/s40264-017-0592-4
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Carrie E. Pierce & Khaled Bouri & Carol Pamer & Scott Proestel & Harold W. Rodriguez & Hoa Le & Clark C. Freifeld & John S. Brownstein & Mark Walderhaug & I. Ralph Edwards & Nabarun Dasgupta, 2017. "Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts," Drug Safety, Springer, vol. 40(4), pages 317-331, April.
- Rebecca E. Chandler & Kristina Juhlin & Jonas Fransson & Ola Caster & I. Ralph Edwards & G. Niklas Norén, 2017. "Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase®," Drug Safety, Springer, vol. 40(1), pages 81-90, January.
- Yuan Luo & William K. Thompson & Timothy M. Herr & Zexian Zeng & Mark A. Berendsen & Siddhartha R. Jonnalagadda & Matthew B. Carson & Justin Starren, 2017. "Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review," Drug Safety, Springer, vol. 40(11), pages 1075-1089, November.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Janet Sultana & Ugo Moretti & Antonio Addis & Pia Caduff & Annalisa Capuano & Agnes Kant & Joan-Ramon Laporte & Marie Lindquist & June Raine & Daniele Sartori & Gianluca Trifirò & Marco Tuccori & Maur, 2019. "Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives," Drug Safety, Springer, vol. 42(5), pages 683-687, May.
- Vassilis Koutkias, 2019. "From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data," Drug Safety, Springer, vol. 42(5), pages 583-586, May.
- Gianluca Trifirò & Rosa Gini & Francesco Barone-Adesi & Ettore Beghi & Anna Cantarutti & Annalisa Capuano & Carla Carnovale & Antonio Clavenna & Mirosa Dellagiovanna & Carmen Ferrajolo & Matteo Franch, 2019. "The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand?," Drug Safety, Springer, vol. 42(3), pages 347-363, March.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Yiqing Zhao & Yue Yu & Hanyin Wang & Yikuan Li & Yu Deng & Guoqian Jiang & Yuan Luo, 2022. "Machine Learning in Causal Inference: Application in Pharmacovigilance," Drug Safety, Springer, vol. 45(5), pages 459-476, May.
- Rybinski, Krzysztof, 2020. "The forecasting power of the multi-language narrative of sell-side research: A machine learning evaluation," Finance Research Letters, Elsevier, vol. 34(C).
- Doris Chenguang Wu & Shiteng Zhong & Richard T R Qiu & Ji Wu, 2022. "Are customer reviews just reviews? Hotel forecasting using sentiment analysis," Tourism Economics, , vol. 28(3), pages 795-816, May.
- Rybinski, Krzysztof, 2021. "Ranking professional forecasters by the predictive power of their narratives," International Journal of Forecasting, Elsevier, vol. 37(1), pages 186-204.
- Lucie M. Gattepaille & Sara Hedfors Vidlin & Tomas Bergvall & Carrie E. Pierce & Johan Ellenius, 2020. "Prospective Evaluation of Adverse Event Recognition Systems in Twitter: Results from the Web-RADR Project," Drug Safety, Springer, vol. 43(8), pages 797-808, August.
- Camille Goyer & Genaro Castillon & Yola Moride, 2022. "Implementation of Interventions and Policies on Opioids and Awareness of Opioid-Related Harms in Canada: A Multistage Mixed Methods Descriptive Study," IJERPH, MDPI, vol. 19(9), pages 1-12, April.
- Corine Ekhart & Florence Hunsel & Eugène Puijenbroek & Rebecca Chandler & Eva-Lisa Meldau & Henric Taavola & G. Niklas Norén, 2022. "Post-Marketing Safety Profile of Vortioxetine Using a Cluster Analysis and a Disproportionality Analysis of Global Adverse Event Reports," Drug Safety, Springer, vol. 45(2), pages 145-153, February.
- Andrew Bate & Steve F. Hobbiger, 2021. "Artificial Intelligence, Real-World Automation and the Safety of Medicines," Drug Safety, Springer, vol. 44(2), pages 125-132, February.
- Juergen Dietrich & Lucie M. Gattepaille & Britta Anne Grum & Letitia Jiri & Magnus Lerch & Daniele Sartori & Antoni Wisniewski, 2020. "Adverse Events in Twitter-Development of a Benchmark Reference Dataset: Results from IMI WEB-RADR," Drug Safety, Springer, vol. 43(5), pages 467-478, May.
- Na Zhang & Ping Yu & Yupeng Li & Wei Gao, 2022. "Research on the Evolution of Consumers’ Purchase Intention Based on Online Reviews and Opinion Dynamics," Sustainability, MDPI, vol. 14(24), pages 1-26, December.
- Ying Li & Antonio Jimeno Yepes & Cao Xiao, 2020. "Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions," Drug Safety, Springer, vol. 43(9), pages 893-903, September.
- Tavpritesh Sethi & Nigam H. Shah, 2017. "Pharmacovigilance Using Textual Data: The Need to Go Deeper and Wider into the Con(text)," Drug Safety, Springer, vol. 40(11), pages 1047-1048, November.
- Apostolos G. Katsafados & Dimitris Anastasiou, 2024.
"Short-term prediction of bank deposit flows: do textual features matter?,"
Annals of Operations Research, Springer, vol. 338(2), pages 947-972, July.
- Katsafados, Apostolos & Anastasiou, Dimitris, 2022. "Short-term Prediction of Bank Deposit Flows: Do Textual Features matter?," MPRA Paper 111418, University Library of Munich, Germany.
- Rebecca E. Chandler, 2017. "Safety Concerns with HPV Vaccines Continue to Linger: Are Current Vaccine Pharmacovigilance Practices Sufficient?," Drug Safety, Springer, vol. 40(12), pages 1167-1170, December.
- Karen Smith & Su Golder & Abeed Sarker & Yoon Loke & Karen O’Connor & Graciela Gonzalez-Hernandez, 2018. "Methods to Compare Adverse Events in Twitter to FAERS, Drug Information Databases, and Systematic Reviews: Proof of Concept with Adalimumab," Drug Safety, Springer, vol. 41(12), pages 1397-1410, December.
- Vicki Osborne & Saad A. W. Shakir, 2018. "The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance," Drug Safety, Springer, vol. 41(1), pages 139-141, January.
- Kristine Macartney & Anastasia Phillips & Cyra Patel & Alexis Pillsbury & Julia Brotherton, 2018. "Authors’ reply: Safety of Human Papillomavirus Vaccines," Drug Safety, Springer, vol. 41(5), pages 541-543, May.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:41:y:2018:i:2:d:10.1007_s40264-017-0592-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.